Category: Wars

Posted on

Why Is Rempel Silent On Harmful Effects Of “Interim Authorized” Vaccines?

Rempel is tied the World Economic Forum, as are many “Conservatives”. Don’t worry, it won’t impact how she does her job. She’ll stand up for Canadians on making sure these “vaccines” are safe.

At least these are safe, right? At least these “vaccines” have gone through all the steps to become approved by Health Canada, correct? These aren’t allowed onto the market by some emergency authorization?

So, Michelle Rempel-Garner is a sell out to big pharma. But at least the Conservative Party of Canada is taking seriously the vast array of civil rights abuses going on in Canada.

Remember: voting works.
Vote next election.

WHO Paper On MANDATORY Vaccination April 13, 2021 (Original)
WHO Paper On MANDATORY Vaccination April 13, 2021 (Copy)
Section 30.1 Canada Food & Drug Act
September 2020 Interim Order From Patty Hajdu
https://www.canada.ca/en/public-health/news/2020/12/government-of-canada-announces-pan-canadian-vaccine-injury-support-program.html
https://covid-vaccine.canada.ca/info/pdf/astrazeneca-covid-19-vaccine-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/janssen-covid-19-vaccine-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/covid-19-vaccine-moderna-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/pfizer-biontech-covid-19-vaccine-pm1-en.pdf

Vaccines Supported For Pregnant Women, Despite No Testing
Vaccines Given “Interim Authorization”, Not Approval. Very Different
Call Centers Wrongly Telling People “Vaccines” Are Approved
Ontario Adds, Then Removes Protections Against “No Jab, No Job”
WHO April 13 Paper: Discussion On Mandatory “Experimental Vaxx”

Posted on

CV #24(D): Heidi Larson; LSHTM; VCP; Vaxxing Pregnant Women; Financed By Big Pharma

Heidi Larson is a bit of a superstar for the pharmaceutical industry, and its allies. It’s well known that GAVI, the Global Alliance for Vaccines and Immunization, is heavily funded by the Gates Foundation, and big pharama. GAVI has also been lobbying the Canadian Parliament for years, and getting hundreds of millions of dollars in grants.

A bit of background information here. The VCP, Vaccine Confidence Program, is part of the LSHTM, or London School of Hygiene & Tropical Medicine. Both receive extensive funding from pharmaceutical companies, the Bill & Melinda Gates Foundation, the World Health Organization, and Governments.

Who else is worth noting?

  • Board member, Carlos Alban (AbbVie)
  • Board member, Bill Anderson (Roche)
  • Board Member, Gabriel Baertschi (Grünenthal)
  • Board member, Anders Blanck (LIF)
  • Board Member, Olivier Charmeil (Sanofi)
  • Board Member, Alberto Chiesi (Chiesi)
  • Board member, Frank Clyburn (MSD)
  • Board Member, Eric Cornut (Menarini)
  • Board member, Richard Daniell (Teva Pharmaceutical Europe)
  • Board member, Johanna Friedl-Naderer (Biogen)
  • Board Member, Murdo Gordon (Amgen)
  • Board member, Peter Guenter (Merck)
  • Board member, Angela Hwang (Pfizer)
  • Board member, Enrica Giorgetti (Farmindustria)
  • Board member, Dirk Kosche (Astellas)
  • Board member, Jean-Luc Lowinski (Pierre Fabre)
  • Board member, Catherine Mazzacco (LEO Pharma)
  • Board member, Johanna Mercier (Gilead)
  • Board member, Luke Miels (GSK)
  • Board member, Gianfranco Nazzi (Almirall)
  • Board member, Oliver O’Connor (IPHA)
  • Board Member, Stefan Oelrich (Bayer)
  • Board member, Giles Platford (Takeda)
  • Board member, Antonio Portela (Bial)
  • Board member, Iskra Reic (AstraZeneca)
  • Board Member, Susanne Schaffert (Novartis)
  • Board member, Stefan Schulze (VIFOR PHARMA)
  • Board Member, Kris Sterkens (Johnson & Johnson)
  • Board member, Han Steutel (vfa)
  • Board member, Alfonso Zulueta (Eli Lilly)

One of the major donors of the Vaccine Confidence Project is the European Federation of Pharmaceutical Industries and Associations (EFPIA). It’s Board is made of up members representing major big pharma companies.

Another donor of VCP is the Innovative Medicine Institute. Salah-Dine Chibout is on the Governing Board of IMI, and also is the Global Head of Discovery and Investigational Safety at Novartis. Additionally, Paul Stoffels is the Chief Scientific Officer at Johnson & Johnson, Worldwide Chairman of Janssen Pharmaceutical Companies of Johnson & Johnson.

The VCP also works closely with the World Health Organization, and is supportive of its mass vaccination agenda. The role with WHO is simply to market the programs to make them more effective.

The Gates Foundation has financial connections to WHO, GAVI, the CDC, and countless pharmaceutical companies. It is also connected to agencies that are involved in computer modelling, such as:
(a) Imperial College London, Neil Ferguson
(b) London School of Hygiene & Tropical Medicine
(c) Vaccine Impact Modelling Consortium

While all of this is nefarious and creepy, where does Heidi Larson fit into this? What role does she play in the system?

Larson works for both VCP and LSHTM. Her job is mostly one of research and consulting into “increasing vaccine confidence”. In layman’s terms, she is looking into ways to convince segments of the population to get vaccines at higher rates. This doesn’t involve research into CREATING safer and more effective products. Instead, it’s done to CONVINCE people that they already are. Her financial connections to companies like GSK and Merck likely influence her work.

Larson and her cronies apparently see nothing wrong with targeting pregnant women, who are the focus of the following article. Yes, damn the consequences, let’s vaxx the preggers. This, and the following information should horrify and enrage normal people.

5. Conclusion
This literature review has shown that both pregnant women and HCW cite safety concerns as a main barrier to obtaining/providing influenza and pertussis vaccines during pregnancy. However responses differed depending on geographical area: inlow-income countries for example, pregnant women were more likely to cite access issues as a barrier to vaccination. There are alsowide gaps in knowledge regarding the attitudes of HCW to vaccination in pregnancy, which is significant considering the impact they have on a woman’s decision to vaccinate.
.
From the supply side, regulatory agencies still do not have a licensing pathway for many vaccines for pregnant women, manufacturers remain concerned about liability and providers perceive that pregnant women are unwilling to accept vaccines [95].
.
As the MDG era comes to an end, the development agenda beyond 2015 is widening to include other important health issues such as non-communicable diseases (NCDs). However, neither still-births nor neonatal deaths are mentioned in post-2015 documents [96] risking that the current momentum for new-born health may be lost.
.
Barriers to vaccination in pregnancy are complex and can differ from barriers and concerns affecting uptake of routine childhood vaccinations. Maternal vaccination is administered at a time when the patient is cautious about various behaviours, including taking medications and vaccinations, and feels responsible for not just her own life but of that foetus. Depending on the cultural context, different norms are also established around the time of pregnancy. Barriers also vary depending on context and target population.
.
Taking these points into account, ‘quick-fix’ interventions which aim to increase vaccination uptake, such as health communication messages and training physicians in communication strategies [97], without understanding addressing the root cause of vaccine hesitancy in specific contexts, are likely to have little effect on patients’ decisions to vaccinate or on the provider’s own confidence in communicating with parents about vaccines.
.
It is important to understand how cultural and gender dynamics in different settings can influence a woman’s decision to vaccinate. This can be done through in-depth local ethnographies, taking the views of all community members and influencers into account, complemented by in-depth individual interviews and focus groups. Research could also examine some of the complex socio-political reasons for under-vaccination in certain communities must to inform vaccination policies and delivery strategies. With more understanding of the perspectives of pregnant women, their providers and communities, maternal vaccine strategies will be more likely to reach and protect pregnant women and their newborns from preventable disease.

Rather than reading the entire paper, that’s the conclusion. First, it’s pointed out that vaccine manufacturers are concerned about liability. So they are fully aware of the damage and exposure their products can bring. Second, it’s acknowledged that women feel responsibility for not just themselves, but the baby as well. This can be manipulated and it ties into the third point, that specific messaging needs to be used on this group. Fourth, specific training to “sell” the vaccines will likely be needed. Fifth, it is higher vaccination rates, not overall safety, that is the focus.

The reference list is extensive.
Check out the actual paper.

That is interesting. Not only is Larson working for the LSHTM and Vaccine Confidence Program, but she has also been employed by pharmaceutical companies GlaxoSmithKline and Merck.

Vaccine confidence concerns the belief that vaccination – and by extension the providers and range of private sector and political entities behind it – serves the best health interests of the public and its constituents. The Oxford English Dictionary defines confidence as “the mental attitude of trusting in or relying on a person or thing”. In light of that, we are not examining the well-studied domain of supply and access barriers to vaccination, but rather what is typically called the “demand” side of immunisation. However, our focus on confidence takes the “demand” rubric a step further than the more traditional notion of building demand through increasing knowledge and awareness of vaccines and immunisation to understanding what else drives confidence in vaccines, and the willingness to accept a vaccine, when supply, access and information are available. In other words, understanding vaccine confidence means understanding the more difficult belief-based, emotional, ideological and contextual factors whose influences often live outside an immunisation or even health programme but affect both confidence in and acceptance of vaccines.

The Vaccine Confidence Program believes that vaccines are good for humanity. It’s a part of the LSHTM, which is one of the biggest modelers of CV-19, predicting death waves. It also receives funding from drug companies who have a product to sell. What we have is a situation where the manufacturers, sales agents, and marketers work together under some humanitarianism guise.

October 2020, Larson co-chaired a panel on combatting pandemic misinformation. It was hosted by LSHTM and Center for Strategic and International Studies.

December 2020, Larson tweeted out — but did not condemn or question — a JAMA Network article discussing mandatory vaccinations.

January 2021, LSHTM tweeted (and Larson retweeted) a Telegraph article on combatting misinformation

January 2021, Larson was at the Pulitzer Center for a talk on combatting misinformation around CV vaccination. A look at their donors reveals the Bill & Melinda Gates Foundation, Facebook, Omidyar Network, Planned Parenthood, and the Rockefeller Foundation.

March 2021, Larson wrote a piece for the New York Times, in support of AstraZeneca. The basic premise was that the AZ vaccine was safe, and that only public perception and confidence were keeping it from being distributed. She also called for “training vaccinators” in such a way to boost the image among others. In short, train people to better sell the product.

Now, this may be a coincidence, but some of the same companies that are paying for Larson’s work “increasing vaccine confidence” are also lobbying Ottawa to buy their products.

Side note with GlaxoSmithKline: Larson has disclosed being a consultant for the company. Now, in 2009, Canada gave Interim Authorization (not approval), to 2 vaccines for H1N1, Arepanrix and Monovalent Vaccine. Lawsuits were filed because the injections harmed a lot of people, but:

[19] The federal Minister of Health authorized the sale of the Arepanrix vaccine pursuant to an interim order dated October 13, 2009. Human trials of the vaccine were still underway. The Minister of Health is empowered to make interim orders if immediate action is required because of a danger to health, safety or the environment. In issuing the interim order, Health Canada deemed the risk profile of Arepanrix to be favourable for an interim order. The authorization was based on the risk caused by the current pandemic threat and its danger to human health. As part of the interim order process, Health Canada agreed to indemnify GSK for any claims brought against it in relation to the administration of the Arepanrix vaccine.

That’s one way to have high confidence in your product: make any sale contingent on getting legal immunity in advance. It’s fair to assume this latest batch came with the same conditions.

Larson’s career appears to have taken off in 2000, then she went to work for UNICEF. No surprise, but she was pushing mass vaccination even then. The bulk of her career appears to be acting as a mouthpiece for big pharma.

Canada announced the launch of a vaccine injury compensation program in December 2020, but so far, so follow-ups have been mentioned.

An interesting side note with Larson’s Twitter profile: she claims that she “did this reluctantly”. That is a strange comment. Does she not believe in what she pushes on the global population?

Anyhow, if nothing else is taken away from here, remember this: the “vaccine confidence” movement is funded by big pharma. They want to convince you that their products are safe. Just ignore the testing issues, and the indemnification agreements.

(1) https://www.vaccineconfidence.org/
(2) https://www.vaccineconfidence.org/team
(3) https://www.vaccineconfidence.org/partners-funders
(4) https://archive.is/Ah9Pw
(5) https://www.efpia.eu/
(6) https://www.efpia.eu/about-us/who-we-are/
(7) https://www.imi.europa.eu/about-imi/governance/governing-board
(8) https://www.who.int/vaccine_safety/initiative/communication/network/vaccineconfidenceproject/en/
(9) Vaccination During Pregnancy Propaganda Research
(10) Vaccine Acceptance During Pregnancy Research
(11) https://www.vaccineconfidence.org/vcp-mission
(12) https://twitter.com/ProfHeidiLarson
(13) https://www.linkedin.com/in/heidi-larson-07b535119/
(14) https://www.csis.org/analysis/call-action-csis-lshtm-high-level-panel-vaccine-confidence-and-misinformation
(15) https://jamanetwork.com/journals/jama/fullarticle/2774712?utm_source=twitter&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=122920#.X-uxuv4Z2-I.twitter
(16) https://www.telegraph.co.uk/global-health/climate-and-people/meet-scientists-tackling-vaccine-misinformation-tiktok/
(17) https://pulitzercenter.org/event/covid-19-vaccines-combating-misinformation
(18) https://pulitzercenter.org/about/donors
(19) https://www.nytimes.com/2021/03/22/opinion/astrazeneca-vaccine-trust.html
(20) https://lobbycanada.gc.ca
(21) https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/legislation-guidelines/interim-orders.html
(22) https://www.canlii.org/en/on/onsc/doc/2019/2019onsc7066/2019onsc7066.html
(23) https://en.wikipedia.org/wiki/Heidi_Larson
(24) https://www.canada.ca/en/public-health/news/2020/12/government-of-canada-announces-pan-canadian-vaccine-injury-support-program.html

CANUCK LAW ON “VACCINE HESITANCY”
(A) Canada’s National Vaccination Strategy
(B) The Vaccine Confidence Project
(C) More Research Into Overcoming “Vaccine Hesitancy”
(D) Psychological Manipulation Over “Vaccine Hesitancy”
(E) World Economic Forum Promoting More Vaccinations
(F) CIHR/NSERC/SSHRC On Grants To Raise Vaccine Uptake
(G) $50,000 Available — Each — For Groups To Target Minorities
(H) Canada Vaccine Innovation Community Challenge

Posted on

Canada Pension Plan Investment Board, And Some Of Their Holdings

The Canadian Pension Plan Investment Board is responsible for investing the money that gets taken from workers’ pay cheques. Now, what does this group actually invest in? The answers may be surprising, as it speaks to the direction they plan to take the fund.

COMPANY AMOUNT
3M Co. $51,203,000
Acceleron Pharma Inc. $85,000
Agios Pharmaceuticals Inc. $1,017,000
Alexion Pharmaceuticals $33,800,000
Alnylam Pharmaceuticals $1,329,000
Amicus Therapeutics $31,186,000
Arrowhead Pharmaceuticals $69,000
Biogen $3,749,000
Biohaven Pharmaceuticals $31,000
China Biologic Products $242,000
CVS Health Corp. $104,361,000
Cardiovascular Sys Inc. $1,339,000
Checkmate Pharmaceuticals $219,000
Eli Lilly & Co. $134,902,000
Fusion Pharmaceuticals $36,624,000
GW Pharmaceuticals $173,115,000
Gilead Sciences $85,944,000
HCA Healthcare $20,325,000
Healthpeak Properties Inc. $43,159,000
Horizon Therapeutics $688,000
Hutchison China Meditech $3,145,000
Ionis Pharmaceuticals $2,414,000
Johnson & Johnson $479,225,000
Ligand Pharmaceuticals $466,000
Magellan Health $5,683,000
Medifast Inc. $641,000
Medpace Holdings Inc. $15,813,000
Merck & Co. $379,344,000
Mirati Therapeutics $61,000
Moderna $75,193,000
Neurocrine Biosciences $752,000
Novavax Inc. $56,000
Opko Health Inc. (Sold off)
Orthofix Med Inc. $976,000
PTC Therapeutics $13,561,000
Pacira Biosciences $13,925,000
Pfizer Inc. $224,969,000
Phillip Morris $128,347,000
Physicians Realty Trust $5,618,000
Prestige Consumer Healthcare $1,022,000
Procter & Gamble $498,019,000
Quest Diagnostics $130,317,000
Reata Pharmaceuticals $323,000
Regeneron Pharmaceuticals $3,233,000
Royalty Pharma $5,420,000
Sabra Healthcare REIT $6,232,000
Sage Therapeutics $735,000
Sigilon Therapeutics $71,333,000
Starr Surgical Co. $21,247,000
Teladoc Health Inc. $4,796,000
Tenet Healthcare Corp. $14,267,000
Teva Pharmaceuticals $1,723,000
Theravance Biopharma $169,000
Thermo Fisher Scientific $198,939,000
Trevi Therapeutics $36,000
Trillium Therapeutics $1,431,000
Ultragenyx Pharmaceutical $1,000
United Therapeutics Corp. $413,000
Unitedhealth Group Inc. $1,067,720,000
Usans Health Sciences $5,867,000
Viatris Inc. $16,153,000
West Pharmaceutical SVSC $410,000
Zimmer Biomet $19,398

Aside from all of the stocks in pharmaceuticals and health care, the CPPIB has interests in many other organizations that will raise eyebrows. True, the “Great Reset” may be a massive conspiracy theory, but the investments here would suggest otherwise.

COMPANY AMOUNT
Alphabet Inc. $2,188,964,000
Amazon Inc. $779,986
American Express $134,979,000
Apple Inc. $979,811,000
Aramark $19,240,000
Autodesk $19,044,000
Bank of America $372,509
Bank of Montreal $62,350
Bank of Nova Scotia $216,553,000
Best Buy $12,943,000
Blackline Inc. $493,000
Blackrock $230,895,000
Blackstone $53,059,000
Boeing $70,565,000
Citigroup $319,809,000
Comcast Corp. $65,150,000
E-Bay $15,259,000
Equifax $135,602,000
Fox Corp. $4,632,000
Hewlett Packard $121,000
Home Depot $274,181,000
Icici Bank Limited $59,222,000
JP Morgan Chase $876,096,000
Mastercard Incorporated $2,236,387,000
Microsoft Corp $1,143,414,000
Molson Coors Beverage $8,593,000
NASDAQ $5,116,000
Newscorp $470,000
Paycom Software $993,000
Paychex Inc. $19,982,000
PayPal Holdings $228,341,000
Pinterest $611,000
Rogers Communications $1,500,000,000
Royal Bank of Canada $537,548,000
Shaw Communications Inc. $100,269,000
Shopify $244,903,000
Starbucks Corp. $32,580,000
Synchrony Financial $5,553,000
Target Corp. $29,903,000
Tesla Inc. $128,538,000
Toronto Dominion Bank $289,035,000
Transunion $37,293,000
Trip Advisor $1,468,000
Twitter Inc. $57,887,000
Uber Technologies $60,382,000
Verizon Communications $192,559,000
Visa Inc. $135,000
Vonage Holdings Corp $145,000
Walmart Inc. $245,483,000
Zoom Video Communications $5,807,000

For reference, Alphabet Inc. is the company that owns Google and its subsidiaries, such as YouTube. It seems that being major stakeholders in the business will have great influence over the social media censorship that Governments ask them to play. CPPIB holds over $2 billion. Difficult to say no to your biggest shareholders.

Additionally the CPPIB holds over $50 million in stock in Twitter. This platform has also been brutal when it comes to censoring views that contradict official pandemic or election narratives.

This is certainly quite in the interesting portfolio: pro-big pharma, and pro-Great Reset. However, there is a bigger and more fundamental problem that needs to be addressed: liabilities.

Year Value of Fund Inv Income Rate of Return
2010 $127.6B $22.1B 14.9%
2011 $148.2B $20.6B 11.9%
2012 $161.6B $9.9B 6.6%
2013 $183.3B $16.7B 10.1%
2014 $219.1B $30.1B 16.5%
2015 $264.6B $40.6B 18.3%
2016 $278.9B $9.1 6.8%
2017 $316.7B $33.5B 11.8%
2018 $356.B $36.7B 11.6%
2019 $392B $32B 8.9%

The CPPIB routinely crows about how well its investments do, and how the fund is worth hundreds of billions of dollars. The problem is that it has a screwy accounting system. Instead of taking into account all assets and liabilities, the health is determined by ability to meet current obligations. The fund has been properly accounted, and there is over $1 trillion in unfunded liabilities. This is money taken in an spent, for which it (should have been) paid out.

Most pension systems act as a ponzi scheme, where the only way to meet old obligations is with the infusion of new money. Clearly, such a system is unsustainable in the long term.

But hey, at least our investments in Pfizer, Moderna, Johnson & Johnson, Gilead, Eli Lilley and 3M are doing well. Good thing there is a “pandemic” to drive up demand for these products.

To hell with free speech and open media.
Big pharma is here to stay.

https://www.sec.gov/edgar/browse/
https://www.sec.gov/edgar/browse/?CIK=1283718
https://www.sec.gov/Archives/edgar/data/1283718/000110465921024475/xslForm13F_X01/infotable.xml
https://www.cppinvestments.com/the-fund/our-performance
https://canucklaw.ca/pensions-1b-unsustainable-underfunded-takes-money-out-of-canada/

Posted on

Ontario Teachers Pension Plan, And The Interesting Stocks They Own

https://twitter.com/ETFOeducators/status/1371865858046365704

The Elementary Teachers Federation of Ontario (ETFO) has publicly called for forcing masks on children, even those in kindergarten. However, not everything is as it appears. For example, the OTPP, the Ontario Teachers Pension Plan, owns $83 million in stock in 3M. This is a company that makes masks.

Also, an honourbale mention and shoutout to Stormhaven, who has covered this, and taken a different approach. Check that piece out as well, as it has lots of good information.

What else is in the OTPP (which includes both elementary and high school teachers)? Information on the holdings can be obtained for free at the U.S. SEC, the Securities and Exchanges Commission.

COMPANY AMOUNT
3M CO $83,000,000
Abbott Labs $355,000
Biogen Inc. $41,915,000
Eli Lilly & Co $1,110,000
Gilead Sciences $1,406,000
Globeus Med Inc. $513,000
Jazz Pharmaceuticals PLC $317,000
Johnson & Johnson $84,386,000
Medpace Holdings Inc. $393,000
Merck & Co. $406,000
Mersana Therapeutics $504,000
Moderna Inc. $970,000
Pfizer $599,000
Procter & Gamble $837,000
Regeneron Pharmaceuticals $736,000
Sarpeta Therapeutics $753,000
TEVA Pharmaceuticals $17,487,000
United Therapeutics Corp. $1,077,000
Vertex Pharmaceuticals $502,000
West Pharmaceutical SVSC $797,000

$83 million in 3M, a company that manufactures facemasks. This is one of those things that makes you go “hmmm….”, doesn’t it?

In addition to owning parts of companies involved in health care and pharmaceuticals, the OTPP has other interests in businesses that will also profit from extended lockdowns, and the “Great Reset”. Here are some of them:

COMPANY AMOUNT
Amazon Group $287,000
Apple $1,104,000
Bank of America Corp $579,000
Black Hills Corp $322,000
Blackstone Group $413,000
Costco Wholesale $943,000
Goldman Sachs $1,714,000
Home Dept $81,854
Kroger Co. $662,000
McDonald’s Corp. $81,651,000
Microsoft $244,167,000
PayPal Holdings $542,000
Pepsico $853,000
Rogers Communications $743,000
Shaw Communications $906,000
Tesla Inc. $561,455,000
Tri Pointe Group Inc. $1,118,000
Twitter Inc. $257,000
Verizon Communications $860,000
Visa Inc. $83,780,000
Zoom Video Communications $392,000

It’s not much of a stretch to see that the OTPP stands to benefit from lockdowns and the “Great Reset”. After all, they are heavily invested in industries and companies that will profit from the current situation.

In addition to owning part of 3M, this Pension Plan also owns considerable stock in Gilead Sciences, Eli Lilly, Merck, Moderna, Pfizer, Teva, and over $84 million in Johnson & Johnson. This could explain their support for the vaccine agenda. Then again, it could all just be a coincidence.

It could also be a coincidence that Jo Taylor, who’s in charge of the OTPP, has ties to the World Economic Forum. Likewise, it may just be happenstance that Mark Wiseman, who runs Blackrock (which owns SNC Lavalin), used to run the CPPIB, and helped set up the OTPP.

Read into it what you will.

(1) https://www.sec.gov/edgar/browse/?CIK=937567
(2) https://archive.is/EFPhz
(3) Submissions At End Of December 2020
(4) https://archive.is/PQnkQ
(5) SEC Filings, Total Pension Fund Assets, December 2020
(6) https://archive.is/SKUga
(7) https://www.weforum.org/agenda/authors/jo-taylor
(8) https://www.weforum.org/people/mark-wiseman

(9) Ontario Teachers, World Economic Forum
(10) Healthcare Of Ontario Pension Plan’s Holdings

Posted on

Another Toronto Court Challenge, But Will This One Actually Go Anywhere?

There was an online announcement of a Notice of Application filed in the Toronto Branch of Ontario Superior Court, Civil Division. Predictably, it caused a buzz in the alternative media. Several commented that it was disappointing the mainstream outlets chose not to cover it.

While that is a valid point, there is another one to raise: how come other complaints have dropped off of people’s radars? There was one filed in October 2019 that is collecting dust 18 months later. There is also a high profile suit filed July 2020 with no defenses submitted almost a year later. True, there was a temporary moratorium on filing deadlines, but that lapsed September 14, 2020. There doesn’t appear to have been any attempt to either force that case ahead, or seek default judgement.

The average person may not know this, but it’s quite easy to search for a case in Ontario and see what progress, if any, has been made. If Parties aren’t even represented, that can also be found out.

Despite there being no movement in those cases, a defamation lawsuit was filed in December 2020. Interesting how actual human rights violations are worth only $11 million, but mean words on Twitter is worth $12.75 million. Perhaps there is some deeper insight that isn’t obvious.

Now, what people choose to do in their private lives is their business. That being said, when asking for donations from the public to finance a lawsuit, it’s worthwhile to ensure the money is going where it’s supposed to be.

One example last year was Action4Canada/Liberty Talk raising money for the promise of a lawsuit in B.C., against Bonnie Henry. Now, the fundraising started in September 2020 (if not earlier), so that has been 8 months now. The promised lawsuit has not materialized. Odessa Orlewicz has spoken about pocketing 25% of it.

It sounds great (on the surface) that another challenge was launched. However, it must be asked: will anything become of it? Or will it fade away, like its predecessors?

On the topic of covering court cases: it’s worth pointing out that various Libel & Slander Acts provide a number of defenses for people reporting on them. These include truth, opinion, public interest, and acting in good faith. Also, there are anti-SLAPP laws (strategic lawsuits against public participation), that ensure reporters and journalists will have a wide breadth to cover important events. For anyone wanting to publish information on court cases, this is important to know.

Posted on

Healthcare Of Ontario Pension Plan (HOOPP) Owns Stock In Vaccines & Masks Being Pushed

The Ontario Science Table lists groups in the health care sector as its partners. Whether or not the individual members support this, and to what extent, the pensions of a lot of people are tied up in promoting their agenda.

HOOPP, the Healthcare of Ontario Pension Plan has some interesting medical holdings. This is at least according the SEC, or U.S. Securities and Exchanges Commission. While there is nothing inherently bad in investing in your own field, it will be driven by the way you want it to go.

The fund claims to have over $100 billion in net assets, or equity. Fair enough, let’s take a look at where some of that money is.

COMPANY AMOUNT
1Life Healthcare $540,000
3M Co. $462,000
Alexion Pharmaceuticals $34,891,000
Alnylam Pharmaceuticals $213,000
Alpha Healthcare Acquisition Corp $2,232,000
Amplitude Health Care Acquisition $930,000
Bausch Health Cos $2,366,000
Biogen Inc. $235,000
CVS Health Corp $32,871
Cytomx Therapeutics Inc. $835,000
Deerfield Healthcare Technology Acquisition $2,696,000
DFP Healthcare Acquisition $3,633,000
Gilead Sciences $6,420,000
HCA Healthcare $142,000
Healthcare Merger Corp. $1,019,000
Jazz Pharmaceuticals PLC $3,538,000
Johnson & Johnson $34,401,000
Livongo Health Inc. $6,169,000
Merck & Co. $6,221,000
Pfizer $38,467,000
Regeneron Pharmaceuticals $1,052,000

The individual companies weren’t named in the HOOPP paperwork, so a visit to the SEC was needed for that. For reference, Gilead is the manufacturer of Veklury, also known as Remdesivir, a drug (not a vaccine) to counter Covid-19. It was given interim authorization to be used in Canada. Janssen (which is owned by Johnson & Johnson) also has an authorized “vaccine” in Canada. So does Pfizer, which is partnered with BioNTech. Yes, these are the same companies.

As for the next group, this is on the list of things that will make you go “hmmm”. If health care workers in Ontario were expecting, or wanting, a shutdown of society, these would be the companies to invest in.

A serious question: does it come across as a conflict of interest when health care workers are pushing pharmaceuticals which their pension plans own stock in? And it gets stranger.

COMPANY AMOUNT
Alibaba Group Holdings $730,000,000
Alphabet Inc. $4,799,000
Amazon $18,848
Beyond Meat Inc. $151,000
Blackline Software $16,000
Blackrock $85,000
Blackstone Group $625,000
Broadcom Inc. $181,000
Coca Cola Co. $58,552,000
Dish Network Corporation $89,000
E-Bay $101,000
Facebook $24,022,000
Goldman Sachs $15,978,000
Grid Dynamics Inc. $4,676,000
Mastercard $427,644,000
Microsoft Corp. $298,081
Netflix $335,000
Nike $2,354
PayPal Holdings $378,000
Salesforce $2,746,000
Shaw Communications $6,386,000
Shopify $50,537,000
Starbucks $11,065,000
Visa $1,802,000
Walmart $13,148,000
Zoom Communications $216,000

HOOPP seems to be investing in everything that we need in order to have a cashless society, working from home, and an abundance of pharmaceuticals. But that’s probably just a coincidence.

While most of the profiles of the HOOPP leadership were privatized, a few were in the open. Some interesting details revealed in them.

Tanya Pereira is the Senior Director of Operations at HOOPP. She is also a Strategic Advisor at Andone Pharmaceuticals, during that same time period.

John Watson is the Director of Operations Support at HOOPP. He has also been charge of other pension plans. Early in his career, he was a records supervisor at Sick Kids Hospital Toronto, which gets significant funding from the Gates Foundation.

HOOPP claims to be pushing the ESG/green agenda pretty hard. So expect that they’ll only be investing in such companies that “appear” to be green, regardless of whether or not they actually are green. They sing the praises about sustainability and climate change. Most people have heard it all before.

As for the HOOPP owning stock in these vaccines and masks, and their members pushing them on the public, that is downright shady, to say the least. True, it’s the doctors and nurses themselves who market it to the lay person, but how does this look?

Is this ancient? According to the SEC, it covers the period up to December 31, 2020, and was filed on March 1, 2021. Now, it’s possible that these shares have since been sold, but the first interim authorizations were coming out before then. Again, how does it look?

IMPORTANT LINKS
(1) https://hoopp.com/
(2) https://hoopp.com/about-hoopp
(3) https://hoopp.com/investments/pension-plan-performance-and-hoopp-annual-report
(4) https://hoopp.com/about-hoopp/pension-leadership
(5) https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/list-drugs.html
(6) https://covid-vaccine.canada.ca/veklury/product-details
(7) https://covid-vaccine.canada.ca/janssen-covid-19-vaccine/product-details
https://www.sec.gov/Archives/edgar/data/1535845/000153584520000007/0001535845-20-000007-index.htm
https://www.sec.gov/Archives/edgar/data/1535845/000153584520000007/xslForm13F_X01/SEC13F09_2020.xml
https://archive.is/Kqazd

EARLIER IN THIS SERIES
(a) Michael Warner Financially Benefits From Prolonged Lockdowns
(b) Who Is Ontario Deputy Medical Officer, Barbara Yaffe?
(c) OST, Monopoly From The University Of Toronto Connected
(d) OST, University Of Toronto, Look At Their Members And Partners
(e) OST’s Robert Steiner Claims To Be Behind PHAC Canada Creation
(f) OST’s Kwame McKenzie Headed 2017 UBI Pilot Project
(g) OST UofT Prelude Actually Set Out In May 2019
(h) OST’s Murty Has Tech Firm That Benefits From Lockdowns
(i) OST: Como Foundation Gives Trillium Health Partners $5M
(j) OST: Current PHO Officials Also Sitting On As Partners
(k) OST: Canadian Agency For Drugs & Technologies In Health; pCPA
(l) OST: Centre For Effective Practice Gets Money From Lockdown
(m) OST: Cochrane Canada; WHO; McMaster University
(n) OST: SPOR Evidence Alliance Gets Funding From WHO